Skip to content
To the full analysis

CONMED stock: balance sheet and debt

CNMD
$50.48Closing price of 12 Nov 2026MEQIRI Score 68 out of 100

CONMED has a debt to equity ratio of 0.81 and an interest coverage of 3.3x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.81
Interest coverage
3.3x
Current ratio
2.14
Cash & equivalents
$40.82M
Total assets
$2.33B
Equity ratio
44.4%
Goodwill
$807.01M
Plus intangible assets of $582.05M
Net debt
$794.13M

Total assets and equity ratio

How large the balance sheet of CONMED Corporation is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$861.57M$481.65M$290.51M51.1%$263.99M
2007$893.95M$481.32M$289.51M56.5%$211.14M
2008$931.66M$486.18M$290.25M57.1%$187.56M
2009$957.5M$481.35M$290.51M60.2%$175.18M
2010$985.77M$485.16M$295.07M59.5%$183.2M
2011$935.59M$430.35M$234.82M61.3%$117.46M
2012$1.08B$447.63M$256.82M56.0%$138.13M
2013$1.09B$567.87M$248.43M55.6%$161.13M
2014$1.1B$572.67M$256.23M52.9%$175.1M
2015$1.11B$568.82M$260.65M52.6%$196.97M
2016$1.33B$817.21M$397.66M43.7%$460.86M
2017$1.36B$816.89M$401.95M46.5%$453.82M
2018$1.37B$813.63M$400.44M48.4%$439.39M
2019$1.78B$1.15B$618.04M40.0%$767.32M
2020$1.75B$1.12B$618.44M40.5%$749.09M
2021$1.77B$1.09B$617.53M44.5%$663.81M
2022$2.3B$1.5B$815.43M32.4%$1.03B
2023$2.3B$1.46B$806.84M36.3%$966.96M
2024$2.31B$1.42B$805.36M41.7%$881.32M
2025$2.33B$1.39B$807.01M44.4%$794.13M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$3.83M$440.35M$267.82M0.61
2007$11.7M$505M$222.83M0.44
2008$11.81M$531.73M$199.38M0.37
2009$9.19M$576.52M$184.37M0.32
2010$12.42M$586.56M$195.62M0.33
2011$26.05M$573.07M$143.51M0.25
2012$23.72M$607M$161.85M0.27
2013$54.44M$606.32M$215.58M0.36
2014$66.33M$581.3M$241.44M0.42
2015$72.5M$585.07M$269.47M0.46
2016$27.43M$580.58M$488.29M0.84
2017$32.62M$631.43M$486.44M0.77
2018$17.51M$662.27M$456.9M0.69
2019$25.86M$710.47M$793.17M1.12
2020$27.36M$709.04M$776.45M1.1
2021$20.85M$785.44M$684.66M0.87
2022$28.94M$745.55M$1.05B1.41
2023$24.3M$834.22M$991.25M1.19
2024$24.46M$962.68M$905.78M0.94
2025$40.82M$1.03B$834.94M0.81

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Mar 2024)
  • Valuation signal Undervalued since 7 Nov 2026, previously Fairly valued
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy